Begin main content

Reports

We found 4707 result(s)

ulipristal acetate (Fibristal)

Last Updated: June 26, 2017
Result type: Reports
Product Line: Common Drug Review
Generic Name: ulipristal acetate
Indications: Uterine fibroids (signs and symptoms)

  • Brand Name: Fibristal
  • Manufacturer: Allergan Inc.
  • Project Number: SF0528-000
  • Project Status: Active
  • Submission Type: RequestForAdvice

Tags

Gynecology/obstetrics

glecaprevir pibrentasvir (TBC)

Last Updated: June 26, 2017
Result type: Reports
Product Line: Common Drug Review
Generic Name: glecaprevir pibrentasvir
Indications: Hepatitis C, chronic

  • Brand Name: TBC
  • Manufacturer: AbbVie Corporation
  • Project Number: SR0523-000
  • Project Status: Active
  • Submission Type: New

migalastat (Galafold)

Last Updated: June 26, 2017
Result type: Reports
Product Line: Common Drug Review
Generic Name: migalastat
Indications: Fabry Disease

  • Brand Name: Galafold
  • Manufacturer: Amicus Therapeutics
  • Project Number: SR0522-000
  • Project Status: Active
  • Submission Type: New

Tags

Genetics, Nervous System, Genetics, Nervous system

cyclosporine (Ikervis)

Last Updated: June 21, 2017
Result type: Reports
Product Line: Common Drug Review
Generic Name: cyclosporine
Indications: keratitis, severe

  • Brand Name: Ikervis
  • Manufacturer: Santen Canada Incorporated
  • Project Number: SR0518-000
  • Project Status: Active
  • Submission Type: New

Tags

Eye

lixisenatide (Adlyxine )

Last Updated: June 22, 2017
Result type: Reports
Product Line: Common Drug Review
Generic Name: lixisenatide
Indications: Diabetes mellitus, Type 2

  • Brand Name: Adlyxine
  • Manufacturer: Sanofi-aventis Canada Inc.
  • Project Number: SR0520-000
  • Project Status: Active
  • Submission Type: New

Tags

Diabetes

ocrelizumab (TBC)

Last Updated: June 21, 2017
Result type: Reports
Product Line: Common Drug Review
Generic Name: ocrelizumab
Indications: multiple sclerosis, relapsing

  • Brand Name: TBC
  • Manufacturer: Hoffman-La Roche Limited
  • Project Number: SR0519-000
  • Project Status: Active
  • Submission Type: New

Tags

Multiple Sclerosis, Multiple sclerosis

insulin degludec (Tresiba)

Last Updated: June 21, 2017
Result type: Reports
Product Line: Common Drug Review
Generic Name: insulin degludec
Indications: Diabetes mellitus, Type 1 & 2

  • Brand Name: Tresiba
  • Manufacturer: Novo Nordisk Canada Inc.
  • Project Number: SR0521-000
  • Project Status: Active
  • Submission Type: New

Tags

Diabetes

abobotulinumtoxinA (Dysport Therapeutic )

Last Updated: June 14, 2017
Result type: Reports
Product Line: Common Drug Review
Generic Name: abobotulinumtoxinA
Indications: Upper limb spasticity

  • Brand Name: Dysport Therapeutic
  • Manufacturer: IPSEN Biopharmaceuticals Canada, Inc.
  • Project Number: SR0517-000
  • Project Status: Active
  • Submission Type: NewIndication

Tags

Nervous System, Botulinum Toxins, Type A, Muscle Hypertonia, Muscle Hypotonia, Upper Extremity, Nervous system, botulinum neurotoxin; botulinum neurotoxins; botulinum toxin a; Spasticity; upper extremities; upper limbs

Current Practice Analysis: Interventions for Insomnia Disorder

Published on: June 23, 2017
Result type: Reports
Product Line: Optimal Use
opens in document viewer

Introduction CADTH studied the use of interventions to treat insomnia disorder (acute and chronic) in Canadian primary care practice. The study investigated current practices and trends in drug and non-drug therapies for patients with insomnia disorder from the perspective of family physicians, nurse practitioners, and pharmacists. The findings ...

  • Project Number: OP0527